{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:06:10Z","timestamp":1791421570131,"version":"4.3.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.cyto.2013.03.007","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T02:06:30Z","timestamp":1365041190000},"page":"272-277","source":"Crossref","is-referenced-by-count":31,"title":["Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis"],"prefix":"10.1016","volume":"62","author":[{"given":"Sayaka","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotoshi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Yachie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2004","key":"10.1016\/j.cyto.2013.03.007_b0005","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton","volume":"31","author":"Petty","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2013.03.007_b0010","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/art.21049","article-title":"Association between the PTPN22gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene","volume":"52","author":"Hinks","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2013.03.007_b0015","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/rheumatology\/41.10.1183","volume":"41","author":"Thomson","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2013.03.007_b0020","doi-asserted-by":"crossref","first-page":"R178","DOI":"10.1186\/ar2088","article-title":"Novel self-epitopes derived from aggrecan, fibrillin, and matrixmetalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health","volume":"8","author":"Kamphuis","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cyto.2013.03.007_b0025","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/MOP.0b013e32834cba24","article-title":"Update on the pathogenesis and treatment of systemic idiopathic arthritis","volume":"23","author":"Sikora","year":"2011","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.cyto.2013.03.007_b0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2012.3","article-title":"Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment","volume":"13","author":"Ravelli","year":"2012","journal-title":"Genes Immun"},{"key":"10.1016\/j.cyto.2013.03.007_b0035","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"aninterleukin-1-like cytokine that signals via the IL-1receptor-related protein ST2 and induces T helper type2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2013.03.007_b0040","doi-asserted-by":"crossref","first-page":"18581","DOI":"10.1073\/pnas.1003059107","article-title":"IL-33 is a crucial amplifier of innate rather than acquired immunity","volume":"107","author":"Oboki","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2013.03.007_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4781(91)90029-L","article-title":"Molecular cloning of the murine ST2 gene: characterization andchromosomal mapping","volume":"1090","author":"Tominaga","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cyto.2013.03.007_b0050","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/j.1460-2075.1994.tb06367.x","article-title":"Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor","volume":"13","author":"Bergers","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.cyto.2013.03.007_b0055","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.164.2.2008120","article-title":"Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation","volume":"164","author":"Oshikawa","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cyto.2013.03.007_b0060","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/eji.200737547","article-title":"IL-33 is a chemoattractant for human Th2 cells","volume":"37","author":"Komai-Koma","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2013.03.007_b0065","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cyto.2007.09.013","article-title":"Interleukin (IL)-33 induces the release of pro-inflammatorymediators by mast cells","volume":"40","author":"Moulin","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2013.03.007_b0070","doi-asserted-by":"crossref","first-page":"019","DOI":"10.1093\/intimm\/dxn060","article-title":"IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells","volume":"20","author":"Smithgall","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.cyto.2013.03.007_b0075","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/eji.200838575","article-title":"The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production","volume":"39","author":"Bourgeois","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2013.03.007_b0080","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.4049\/jimmunol.0901575","article-title":"IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation","volume":"183","author":"Kurowska-Stolarska","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2013.03.007_b0085","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.02.026","article-title":"IL-33-activated dendritic cells induce an atypical TH2-type response","volume":"123","author":"Rank","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cyto.2013.03.007_b0090","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1002\/eji.201141629","article-title":"IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8(?) T cells","volume":"41","author":"Yang","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2013.03.007_b0095","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.4049\/jimmunol.166.11.6633","article-title":"A novel pathway regulating lipopolysaccharide-induced shock by ST2\/T1 via inhibition of Toll-like receptor 4 expression","volume":"166","author":"Sweet","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2013.03.007_b0100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/rheumatology\/kep402","article-title":"Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus","volume":"49","author":"Mok","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2013.03.007_b0105","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1378\/chest.124.4.1206","article-title":"The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis","volume":"124","author":"Tajima","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.cyto.2013.03.007_b0110","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","article-title":"Expression and regulation of ST2, an interleukin-1receptor family member, in cardiomyocytes andmyocardial infarction","volume":"106","author":"Weinberg","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2013.03.007_b0115","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.CIR.0000047274.66749.FE","article-title":"Identification of serum soluble ST2 receptor as a novel heart failure biomarker","volume":"107","author":"Weinberg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2013.03.007_b0120","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","article-title":"Preliminarydiagnostic guidelines for macrophage activationsyndrome complicating systemic juvenile idiopathic arthritis","volume":"146","author":"Ravelli","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.cyto.2013.03.007_b0125","first-page":"2290","volume":"31","author":"Wallace","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2013.03.007_b0130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","article-title":"Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions","volume":"7","author":"Mellins","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.cyto.2013.03.007_b0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4049\/jimmunol.173.1.145","article-title":"A novel therapy of murine collagen-induced arthritis with soluble T1\/ST2","volume":"173","author":"Leung","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2013.03.007_b0140","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/eji.201141947","article-title":"IL-33 attenuates experimental autoimmune encephalomyelitis by suppressing IL-17 and IFN-\u03b3 production and inducing alternatively-activated macrophages","volume":"42","author":"Jiang","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2013.03.007_b0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3899\/jrheum.090492","article-title":"Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis","volume":"37","author":"Matsuyama","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2013.03.007_b0150","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3899\/jrheum.100184","article-title":"Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis","volume":"37","author":"Mu","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2013.03.007_b0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cyto.2011.12.010","article-title":"Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis","volume":"58","author":"Xiangyang","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2013.03.007_b0160","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s10067-011-1843-x","article-title":"Serum levels of IL-33 is increased in patients with ankylosing spondylitis","volume":"30","author":"Han","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cyto.2013.03.007_b0165","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3346\/jkms.2011.26.9.1132","article-title":"Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis","volume":"26","author":"Hong","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.cyto.2013.03.007_b0170","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jbspin.2011.02.011","article-title":"Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis","volume":"79","author":"Talabot-Ayer","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.cyto.2013.03.007_b0175","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00296-011-1854-6","article-title":"Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non- responsive to anti-tumor necrosis factor: possible association with persistent IL-1\u03b2 signaling and a poor clinical response","volume":"32","author":"Matsuyama","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cyto.2013.03.007_b0180","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3899\/jrheum.100184","article-title":"Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis","volume":"37","author":"Mu","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2013.03.007_b0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3899\/jrheum.090492","article-title":"Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis","volume":"37","author":"Matsuyama","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2013.03.007_b0190","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1-likecytokine ligand for ST2 receptor, is a chromatin-associatednuclear factor in vivo","volume":"104","author":"Carriere","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2013.03.007_b0195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cytogfr.2004.02.004","article-title":"T1\/ST2 an IL-1receptor-like modulator of immune responses","volume":"15","author":"Trajkovic","year":"2004","journal-title":"Cytokine Growth Fact Rev"},{"key":"10.1016\/j.cyto.2013.03.007_b0200","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cvr\/cvq104","article-title":"Primary sources and immunological prerequisites for sST2 secretion in humans","volume":"87","author":"Mildner","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"25","key":"10.1016\/j.cyto.2013.03.007_b0205","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.jacc.2008.09.027","article-title":"Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load","volume":"52","author":"Bartunek","year":"2008","journal-title":"J Am Coll Cardiol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466613001099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466613001099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T16:11:30Z","timestamp":1562861490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466613001099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1043466613001099"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2013.03.007","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}